Z-1053-2017 Class II Terminated

Recalled by The Binding Site Group, Ltd. — Birmingham

FDA device recall Z-1053-2017 was initiated by The Binding Site Group, Ltd. on Oct 28, 2016 and is designated Class II. Reason for recall: A change in the calibration curve causing an increase in false prozone flags. The recall status is terminated (terminated Jul 27, 2017). Affected quantity: 3,088.

Recall details

Product Type
Devices
Report Date
Jan 25, 2017
Initiation Date
Oct 28, 2016
Termination Date
Jul 27, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,088

Product description

Freelite Human Lambda Free Kit for use on SPAPLUS Product Code: LK018.S, LK018.10S Freelite aids the detection and monitoring of Multiple Myeloma and related diseases

Reason for recall

A change in the calibration curve causing an increase in false prozone flags.

Distribution pattern

Worldwide Distribution - U.S. (nationwide) and Internationally to the following; Canada, Australia.

Code information

Lot #400012, 400257

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1053-2017
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for The Binding Site Group, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-1053-2017. Report a data issue: hello@regdatalab.com.